Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ferring Pharmaceuticals
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male aged 18 years or older
Diagnosed with prostate cancer
Patient having received an antagonist of GnRH Degarelix prescription.
Agreeing to and capable of completing in French during the visits all questionnaires on the impact of their illness and treatment.
Patients having received oral and written study information, agreeing to the use of his anonymized data, and having signed a written Informed Consent Form.
You may not be if
Patient included in an interventional study assessing treatment for prostate cancer.
Patient presenting hypersensitivity to Degarelix or one of its excipients.
Patient treated by other hormonotherapy.
Clareo Health | Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix
